SaxoCellSystems will develop a supporting automation platform for AI-assisted manufacturing of cell products within the SaxoCell® cluster. This will enable stakeholders to achieve robust scaling of cell production for clinical scale. For this purpose, standardized and reproducible protocols for automated bioreactor culture will be established. This standardization strategy will be achieved through an intelligent generic process model. In parallel, all aspects of intelligent quality management, such as tracking of the production materials used and quality controls, will also be incorporated into the automation. AI methods will be integrated to optimize the main and secondary processes in order to sustainably increase the efficiency of the processes.